Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Stem cells from hair follicles in a special gel show strong potential for bone regeneration.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Hair follicle cells can help keep embryonic stem cells undifferentiated.

Genetic factors, including a variant near the FGF5 gene, contribute to hirsutism and are linked to PCOS and metabolic traits.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Adipokines affect skin health and could be targeted for treating skin diseases.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Skin-derived stem cells grow faster and are easier to obtain than hair follicle stem cells, but both can become various cell types.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

Managing myasthenia gravis is crucial and does not worsen primary Sjögren's syndrome.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

JAK inhibitors show promise for treating alopecia areata, but long-term safety and emotional support are important.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Hypothyroidism may cause certain types of hair loss.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

JAK1 gene variation may increase alopecia areata risk.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Topical minoxidil can cause severe liver failure.

New medications could improve treatment for severe alopecia areata in Australia.